3 providers · Listed against public registers

Best Telehealth GLP-1 Programs in Australia (2026): Juniper, Mosh, Pilot, Compass

Telehealth GLP-1 services bundle online medical consultation + script + medication into a flat monthly subscription, available Australia-wide. Major providers: Juniper (Eucalyptus Health, Sydney HQ — uses Wegovy/Mounjaro), Mosh (independent — Saxenda, Wegovy), Pilot (Eucalyptus — Mounjaro), Compass. Typical cost $290–$450/month covering admin + script. Most providers ship medication directly. Suitable for BMI 30+ (or 27+ with comorbidities) — the standard GLP-1 receptor agonist threshold. NOT covered by PBS for weight loss (only Ozempic with type 2 diabetes is PBS-subsidised). Always discuss with your regular GP first to coordinate care.

The Health Desk · Editorial team, aged care + dental + plastic surgery + dermatology + weight-loss + psychology · Updated 14 May 2026 · How we rank · Editorial standards

★Key takeaways

  • ✓3 listed telehealth glp1 providers across Australia.
  • ✓Longest-established: Juniper (7+ years operating).
  • ✓Independent ranking — no paid placements. Always consult your GP first; they write the referrals + Mental Health Care Plans + PBS Authority codes that unlock pathway-specific funding.
Best Telehealth GLP-1 Programs in Australia (2026): Juniper, Mosh, Pilot, Compass — quick compare table · Click any header to sort
Provider ⇅ Provider (suburb) ⇅ Lead designation ⇅ Years ⇅ ANZMOSS ⇅ GLP-1 ⇅ Programs ⇅
Juniper Surry HillsMBBS, BMedSci, FRACGP (Specialist GP)7+ yrs—YesGLP-1 program (Ozempic/Wegovy), GLP-1 program (Mounjaro)
Pilot Fortitude ValleyMBBS, BMedSci, FRACGP (Specialist GP)7+ yrs—YesGLP-1 program (Ozempic/Wegovy), GLP-1 program (Mounjaro)
Mosh Adelaide CBDAHPRA-registered GPs7+ yrs—YesGLP-1 program (Ozempic/Wegovy), GLP-1 program (Mounjaro)

Top 3 ranked by years operating then ANZMOSS membership. Independent — no paid placements.

1

Juniper

Telehealth GLP-1 GLP-1 prescriber Surry Hills

Juniper operates from Surry Hills, Sydney. 7+ years operating. Lead clinician Dr Matthew Vickers (MBBS, BMedSci, FRACGP (Specialist GP)). Sydney-headquartered Eucalyptus Health brand serving women nationally - now Australia's largest GLP-1 telehealth weight-loss program with peer-reviewed real-world outcomes outperforming clinical trials.

Lead clinician

Dr Matthew Vickers

MBBS, BMedSci, FRACGP (Specialist GP)

Founded

2019

7+ years operating

Programs

3

Programs: GLP-1 program (Ozempic/Wegovy), GLP-1 program (Mounjaro), Behavioural support.

Best for: Patients wanting GLP-1 (Wegovy / Mounjaro / Saxenda) via online subscription, Australia-wide

Sydney-headquartered Eucalyptus Health brand serving women nationally - now Australia's largest GLP-1 telehealth weight-loss program with peer-reviewed real-world outcomes outperforming clinical trials.

Provider website → 1300 152 657
2

Pilot

Telehealth GLP-1 GLP-1 prescriber Fortitude Valley

Pilot operates from Fortitude Valley, Brisbane. 7+ years operating. Lead clinician Dr Matthew Vickers (MBBS, BMedSci, FRACGP (Specialist GP)). Sydney-founded Eucalyptus Health men's brand serving Australia nationally - the largest male-focused GLP-1 weight-loss telehealth program in the country.

Lead clinician

Dr Matthew Vickers

MBBS, BMedSci, FRACGP (Specialist GP)

Founded

2019

7+ years operating

Programs

3

Programs: GLP-1 program (Ozempic/Wegovy), GLP-1 program (Mounjaro), Behavioural support.

Best for: Patients wanting GLP-1 (Wegovy / Mounjaro / Saxenda) via online subscription, Australia-wide

Sydney-founded Eucalyptus Health men's brand serving Australia nationally - the largest male-focused GLP-1 weight-loss telehealth program in the country.

Provider website → 1300 745 685
3

Mosh

Telehealth GLP-1 GLP-1 prescriber Adelaide CBD

Mosh operates from Adelaide CBD, Adelaide. 7+ years operating. Lead clinician Mosh Medical Team (AHPRA-registered GPs). Independent Australian-founded telehealth provider serving patients nationally - combines GLP-1 medication, meal-replacement shakes and accredited dietitian support in a single subscription.

Lead clinician

Mosh Medical Team

AHPRA-registered GPs

Founded

2019

7+ years operating

Programs

4

Programs: GLP-1 program (Ozempic/Wegovy), GLP-1 program (Mounjaro), Very Low Calorie Diet (VLCD), Behavioural support.

Best for: Patients wanting GLP-1 (Wegovy / Mounjaro / Saxenda) via online subscription, Australia-wide

Independent Australian-founded telehealth provider serving patients nationally - combines GLP-1 medication, meal-replacement shakes and accredited dietitian support in a single subscription.

Provider website → 1800 270 936

Common questions

How does telehealth GLP-1 work?

You sign up online, complete a medical history, video-consult with a doctor (typically 15 min), get a prescription, then medication ships to you (or to a partnered pharmacy). Monthly subscription includes ongoing prescription, dose titration, side-effect management, and dietitian/psychology support depending on the platform. No in-person visits required.

Are telehealth GLP-1 services as safe as in-person?

For most BMI 30–40 patients without major comorbidities, yes — the safety profile of GLP-1 is well-documented. Telehealth providers screen for contraindications (medullary thyroid cancer history, MEN-2 syndrome, severe gastroparesis, pregnancy). For patients with multiple comorbidities (heart failure, kidney disease, complex psych history), in-person care offers fuller work-up. Always tell your regular GP what you're taking.

Is GLP-1 covered by Medicare or PBS?

Ozempic (semaglutide 1mg/2mg) IS PBS-subsidised — but ONLY for type 2 diabetes with HbA1c documentation. $31.60/month general script ($7.70 concession). Wegovy (semaglutide 2.4mg for weight loss), Mounjaro (tirzepatide), and Saxenda (liraglutide) are NOT on the PBS for weight loss as at January 2026. Telehealth platforms charge $290–$450/month covering subscription + private script.

How much weight will I lose?

Average GLP-1 weight loss at 12 months: 10–18% of body weight. Wegovy STEP trial: 14.9% mean loss. Mounjaro SURMOUNT-1 trial: 20.9% mean loss at highest dose. Individual response varies; 5–10% lose less than 5% (non-responders, typically considered for surgery instead). Weight regain on stopping is common (~2/3 regained within 12 months without lifestyle change).

What are the side effects?

Most common: nausea (40-60% in first 4 weeks, decreasing with dose titration), constipation, diarrhoea, fatigue. Less common: gallstones (especially with rapid weight loss), pancreatitis (rare), hair thinning. Medullary thyroid cancer warning is theoretical (rodent data). Most side effects manageable with slow titration and dietary changes (smaller meals, lower fat/sugar).